Reducing the Use of Medication and Deprescribing in Patients With Arthritis

20 May 2026
Pharmacy

A session exploring the challenges and risks of opioid use in MSK conditions and how to identify patients who may benefit from opioid tapering using effective communication strategies and evidence-based alternatives.

Learning outcomes:

  • Understand the challenges and risks of opioid use in MSK conditions.
  • Identify patients who may benefit from opioid tapering.
  • Use effective communication strategies.
  • Explore evidence-based alternatives to opioids.
Speakers
Daniel Wardleworth
Daniel Wardleworth, GP Partner, Modality Partnership Group (on behalf of Arthritis UK)